Evidence map›Paper›PMID 22340593›Full record

ArticleCancer cell2012

Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73.

Hiroshi Katayama, Jin Wang, Warapen Treekitkarnmongkol, Hidehiko Kawai, Kaori Sasai, Hui Zhang, Hua Wang, Henry P Adams, Shoulei Jiang, Sandip N Chakraborty and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer cell, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 85 citations in OpenAlex.

  1. Dual Inhibition of TRIP13 and Aurora A Induces Mitotic DNA Damage and Concurrent Pyroptotic-Apoptotic Cell Death in Rb-Deficient Cancer Cells.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A new wave of innovations within the DNA damage response.Signal transduction and targeted therapy · 2023
    Review
  8. Article
  9. Review
  10. Review
  11. The Anaphase-Promoting Complex/Cyclosome Is a Cellular Ageing Regulator.International journal of molecular sciences · 2022
    Review
  12. Aurora kinase a inhibitor MLN8237 suppresses pancreatic cancer growth.Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Hiroshi KatayamaDepartment of Molecular Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77054, USA.
Jin Wang
Warapen Treekitkarnmongkol
Hidehiko Kawai
Kaori Sasai
Hui Zhang
Hua Wang
Henry P Adams
Shoulei Jiang
Sandip N Chakraborty
Fumio Suzuki
Ralph B Arlinghaus
Jinsong Liu
James A Mobley
William E Grizzle
Huamin Wang
Subrata Sen
The University of Texas MD Anderson Cancer Center · USHiroshima University · JPUniversity of Alabama at Birmingham · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
UAB / UMN SPORE in Pancreatic CancerP50CA101955 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BUCHSBAUM, DONALD J · 2010 to 2014
$11.1M
Biomarkers for the Early Detection of Pancreatic CancerU01CA111302 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KILLARY, ANN M, SEN, SUBRATA · 2004 to 2015
$6.6M
Virus adjunctive therapies for pancreatic cancerP20CA101955 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BUCHSBAUM, DONALD J. · 2003 to 2007
$4.6M
Novel human oncogene STK15/BTAK/Aurora 2R01CA089716 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SEN, SUBRATA · 2001 to 2012
$2.3M
NCI NIH HHS 5P30CA0101955NCI NIH HHS CA16872NCI NIH HHS P20 CA101955NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA101955NCI NIH HHS R01 CA089716NCI NIH HHS R01CA089716NCI NIH HHS U01 CA111302NCI NIH HHS U01CA111302
6 · The paper itself

Abstract

Elevated Aurora kinase-A expression is correlated with abrogation of DNA damage-induced apoptotic response and mitotic spindle assembly checkpoint (SAC) override in human tumor cells. We report that Aurora-A phosphorylation of p73 at serine235 abrogates its transactivation function and causes cytoplasmic sequestration in a complex with the chaperon protein mortalin. Aurora-A phosphorylated p73 also facilitates inactivation of SAC through dissociation of the MAD2-CDC20 complex in cells undergoing mitosis. Cells expressing phosphor-mimetic mutant (S235D) of p73 manifest altered growth properties, resistance to cisplatin- induced apoptosis, as well as premature dissociation of the MAD2-CDC20 complex, and accelerated mitotic exit with SAC override in the presence of spindle damage. Elevated cytoplasmic p73 in Aurora-A overexpressing primary human tumors corroborates the experimental findings.

Indexed as

ApoptosisDNA DamageM Phase Cell Cycle CheckpointsAurora Kinase AAurora KinasesDNA-Binding ProteinsHSP70 Heat-Shock ProteinsHumansNuclear ProteinsPancreatic NeoplasmsPhosphorylationProtein Serine-Threonine KinasesTumor Cells, CulturedTumor Protein p73Tumor Suppressor ProteinsAURKA protein, humanAurora Kinase AAurora KinasesDNA-Binding ProteinsHSP70 Heat-Shock ProteinsmortalinNuclear ProteinsProtein Serine-Threonine KinasesTP73 protein, humanTumor Protein p73Tumor Suppressor Proteins

Identifiers

PMID22340593
PMCPMC3760020
OpenAlexW2080186620

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.